Purification of pegylated proteins.

Separation of PEGylated proteins is challenging because PEG itself is a relatively inert, neutral, hydrophilic polymer and the starting point for PEGylation is a pure protein. Thus, other than molecular weight and size, differences in the physicochemical properties typically used to fractionate proteins may be slight between different PEGylated forms of a protein. The usual properties of electrostatic charge and molecular weight (size) form the basis of the most commonly used separation techniques, particularly IEC, SEC, and ultrafiltration. The main effect of PEGylation on ion-exchange separations is to shield the electrostatic charges on the protein surface and to reduce the strength of interactions with higher PEG chain molecular weight or higher PEGylation extent. Thus, ion exchange can be used very effectively to separate on the basis of PEGylation extent for low extents, but as N increases, the effectiveness of separation rapidly diminishes. Separation of positional isomers is possible by RPC or ion exchange at analytical scale, but it is problematic at the preparative scale due to the small size of the differences in electrostatic interactions between isomers. PEGylation imparts significant changes in molecular weight with each chain added to a protein and there are corresponding increases in molecular size, so SEC and ultrafiltration (and dialysis) are effective methods for separating native and PEGylated proteins. However, the relative size difference between variants differing in PEGylation extent by one adduct reduces with N, so that efficient SEC separation between PEGylated species differing by one PEG chain is not likely to be economic at the preparative scale for N > 3. This holds true even for PEG proteins produced with large PEG polymers (Mr > or =20 kDa). For small PEG polymers (Mr = 2 kDa), only native and PEGylated species can be separated effectively. At the analytical scale, with proper calibration, SEC can provide valuable information on PEGylation extent. Membranes can be used to reduce the concentration of smaller molecular weight species by dialysis but cannot fully remove them, and an operational trade-off between purity and yield is required. Gel electrophoresis can confirm PEGylation reactions have proceeded and indicate the relative purity of products, but its use to confirm PEGylation extent requires further research. The main drawback of separations based solely upon molecular size is that they cannot differentiate between positional isomers. Capillary electrophoresis is an exception, quantitatively combining any or all of size, shape, conformational freedom, and small differences in protein surface properties to separate by both PEGylation extent and positional isomerism. Relative hydrophobicity is a useful property for analytical separations using RPC, but HIC, which is used routinely for production-scale purification of proteins, does not appear to be particularly useful for separation of PEGylated species.

[1]  Xiaolan Yang,et al.  Site-Specific PEGylation of Therapeutic Proteins via Optimization of Both Accessible Reactive Amino Acid Residues and PEG Derivatives , 2012, BioDrugs.

[2]  I. Kaltashov,et al.  Structural characterization of protein–polymer conjugates. I. Assessing heterogeneity of a small PEGylated protein and mapping conjugation sites using ion exchange chromatography and top-down tandem mass spectrometry , 2012 .

[3]  F. Veronese,et al.  The Impact of PEGylation on Biological Therapies , 2012, BioDrugs.

[4]  Deqiang Yu,et al.  Purification of PEGylated protein using membrane chromatography. , 2010, Journal of pharmaceutical sciences.

[5]  Dan Qin,et al.  A liquid chromatographic method for determination of the modification degree of proteins: PEGylated arginase as an example. , 2010, Analytical biochemistry.

[6]  Simona Jevševar,et al.  PEGylation of therapeutic proteins , 2010, Biotechnology journal.

[7]  María J. Vicent,et al.  Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. , 2009, Advanced drug delivery reviews.

[8]  Gianfranco Pasut,et al.  PEG conjugates in clinical development or use as anticancer agents: an overview. , 2009, Advanced drug delivery reviews.

[9]  Jiandu Lei,et al.  Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight. , 2009, Journal of biotechnology.

[10]  M. Schiefermeier,et al.  Correlations between in vitro potency of polyethylene glycol-protein conjugates and their chromatographic behavior. , 2009, Analytical biochemistry.

[11]  F. Veronese,et al.  PEGylated Protein Drugs: Basic Science and Clinical Applications , 2009 .

[12]  A. Zydney,et al.  Ultrafiltration of PEGylated proteins: Fouling and concentration polarization effects , 2008 .

[13]  David J Brayden,et al.  Advances in PEGylation of important biotech molecules: delivery aspects , 2008, Expert opinion on drug delivery.

[14]  V. Gaberc-Porekar,et al.  Obstacles and pitfalls in the PEGylation of therapeutic proteins. , 2008, Current opinion in drug discovery & development.

[15]  Darin L. Lee,et al.  Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor. , 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[16]  S. Jevševar,et al.  Size of Pegylated Protein Conjugates Studied by Various Methods , 2008 .

[17]  Shuichi Yamamoto,et al.  Effects of protein conformational changes on separation performance in electrostatic interaction chromatography: unfolded proteins and PEGylated proteins. , 2007, Journal of biotechnology.

[18]  Byung Kook Lee,et al.  Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity. , 2007, Bioconjugate chemistry.

[19]  G. Pasut,et al.  Polymer-drug conjugation, recent achievements and general strategies , 2007 .

[20]  A. Hunter,et al.  Comparison of strong anion-exchangers for the purification of a PEGylated protein. , 2007, Journal of chromatography. A.

[21]  A. Zydney,et al.  Separation of PEGylated α‐Lactalbumin from Unreacted Precursors and Byproducts Using Ultrafiltration , 2007, Biotechnology progress.

[22]  A. Zydney,et al.  Ultrafiltration characteristics of pegylated proteins , 2006, Biotechnology and bioengineering.

[23]  S. Brocchini,et al.  Site-specific PEGylation of native disulfide bonds in therapeutic proteins , 2006, Nature chemical biology.

[24]  J. V. Alstine,et al.  PEG-proteins: Reaction engineering and separation issues , 2006 .

[25]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[26]  M. Grace,et al.  Site of Pegylation and Polyethylene Glycol Molecule Size Attenuate Interferon-α Antiviral and Antiproliferative Activities through the JAK/STAT Signaling Pathway* , 2005, Journal of Biological Chemistry.

[27]  R. Tilton,et al.  Adsorption of poly(ethylene glycol)-modified lysozyme to silica. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[28]  J. V. Van Alstine,et al.  Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylated proteins. , 2004, Bioconjugate chemistry.

[29]  Theodore W Randolph,et al.  Protein-solute interactions affect the outcome of ultrafiltration/diafiltration operations. , 2004, Journal of pharmaceutical sciences.

[30]  Kang-Choon Lee,et al.  Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2004, Analytical biochemistry.

[31]  D. C. Wood,et al.  Preparative and analytical chromatography of pegylated myelopoietin using monolithic media. , 2004, Journal of chromatography. A.

[32]  A. Bernkop‐Schnürch,et al.  Development and in vivo evaluation of an oral insulin-PEG delivery system. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[33]  B. Domon,et al.  Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters. , 2004, Protein expression and purification.

[34]  Haeshin Lee,et al.  Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity , 2002, Pharmaceutical Research.

[35]  Yan-Hui Liu,et al.  Carboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG , 2001, Pharmaceutical Research.

[36]  Kang-Choon Lee,et al.  Isolation, Characterization, and Stability of Positional Isomers of Mono-PEGylated Salmon Calcitonins , 1999, Pharmaceutical Research.

[37]  D. Brems,et al.  Characterization and Stability of N-terminally PEGylated rhG-CSF , 1996, Pharmaceutical Research.

[38]  D. Filpula,et al.  Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation. , 2003, Protein engineering.

[39]  D. Collen,et al.  Clinical development of PEGylated recombinant staphylokinase (PEG-Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction. , 2003, Advanced drug delivery reviews.

[40]  Steven W. Martin,et al.  Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. , 2003, Advanced drug delivery reviews.

[41]  P. Caliceti,et al.  PEGylation of growth hormone-releasing hormone (GRF) analogues. , 2003, Advanced drug delivery reviews.

[42]  V. Hasırcı,et al.  Solid-phase enzyme modification via affinity chromatography. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[43]  Siddharth J. Advant,et al.  Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography. , 2003, Biomedical chromatography : BMC.

[44]  M. Azarkan,et al.  Fractionation and purification of the enzymes stored in the latex of Carica papaya. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[45]  Yasuo Yoshioka,et al.  Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity , 2003, Nature Biotechnology.

[46]  C. Fee Size-exclusion reaction chromatography (SERC): a new technique for protein PEGylation. , 2003, Biotechnology and bioengineering.

[47]  P. K. Smith,et al.  Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. , 2003, Bioconjugate chemistry.

[48]  Haeshin Lee,et al.  A novel method for identifying PEGylation sites of protein using biotinylated PEG derivatives. , 2003, Journal of Pharmacy and Science.

[49]  A. Bolognesi,et al.  Novel poly(ethylene glycol) derivatives for preparation of ribosome-inactivating protein conjugates. , 2002, Bioconjugate chemistry.

[50]  M. Treuheit,et al.  Mono-N-terminal poly(ethylene glycol)-protein conjugates. , 2002, Advanced drug delivery reviews.

[51]  H. Sato,et al.  Enzymatic procedure for site-specific pegylation of proteins. , 2002, Advanced drug delivery reviews.

[52]  A. P. Chapman,et al.  PEGylated antibodies and antibody fragments for improved therapy: a review. , 2002, Advanced drug delivery reviews.

[53]  D. Wyss,et al.  Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. , 2002, Advanced drug delivery reviews.

[54]  S. W. Kim,et al.  Effects of PEG conjugation on insulin properties. , 2002, Advanced drug delivery reviews.

[55]  S. Pedder,et al.  Use of peginterferon alfa-2a (40 KD) (Pegasys) for the treatment of hepatitis C. , 2002, Advanced drug delivery reviews.

[56]  M. Bentley,et al.  Chemistry for peptide and protein PEGylation. , 2002, Advanced drug delivery reviews.

[57]  Tae Gwan Park,et al.  Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. , 2002, Biomaterials.

[58]  P. Esposito,et al.  Set-up of large laboratory-scale chromatographic separations of poly(ethylene glycol) derivatives of the growth hormone-releasing factor 1-29 analogue. , 2002, Journal of chromatography. A.

[59]  R B Greenwald,et al.  PEG drugs: an overview. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[60]  F. Veronese Peptide and protein PEGylation: a review of problems and solutions. , 2001, Biomaterials.

[61]  J. Seely,et al.  Use of ion-exchange chromatography and hydrophobic interaction chromatography in the preparation and recovery of polyethylene glycol-linked proteins. , 2001, Journal of chromatography. A.

[62]  P. Caliceti,et al.  New PEGs for peptide and protein modification, suitable for identification of the PEGylation site. , 2001, Bioconjugate chemistry.

[63]  Z. Su,et al.  Characterization of polyethylene glycol-modified proteins by semi-aqueous capillary electrophoresis. , 2001, Journal of chromatography. A.

[64]  P. Caliceti,et al.  Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine). , 2000, Farmaco.

[65]  Z. Shahrokh,et al.  Modulating pharmacokinetics of an anti-interleukin-8 F(ab')(2) by amine-specific PEGylation with preserved bioactivity. , 2000, International journal of pharmaceutics.

[66]  M. Whitlow,et al.  Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds. , 1999, Bioconjugate chemistry.

[67]  Mariangela Spitali,et al.  Therapeutic antibody fragments with prolonged in vivo half-lives , 1999, Nature Biotechnology.

[68]  P. Shaw,et al.  Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation. , 1999, Life sciences.

[69]  M. Azarkan,et al.  Evaluation of the polyethylene glycol–KF–water system in the context of purifying PEG–protein adducts , 1999 .

[70]  P. Christakopoulos,et al.  Enhancement of pH-stability of a low molecular mass endoglucanase from Fusarium oxysporum by protein pegylation , 1998 .

[71]  A. Hartmann,et al.  Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  T. Ueno,et al.  Pegylation of proteins and bioactive substances for medical and technical applications , 1998 .

[73]  W. Berthold,et al.  Polyethylene glycol-conjugated pharmaceutical proteins , 1998 .

[74]  Martin Malmsten,et al.  Effect of chain density on inhibition of protein adsorption by poly(ethylene glycol) based coatings , 1998 .

[75]  R. Hoffman,et al.  Polyethylene glycol conjugation of recombinant methioninase for cancer therapy. , 1998, Protein expression and purification.

[76]  Samuel Zalipsky,et al.  Poly(ethylene glycol): Chemistry and Biological Applications , 1997 .

[77]  M. Malmsten,et al.  Analytical partitioning of poly(ethylene glycol)-modified proteins. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[78]  M. Azarkan,et al.  Preliminary characterization of bovine beta-lactoglobulin after its conjugation to polyethylene glycol. , 1997, Biotechnology and bioengineering.

[79]  R. Paxton,et al.  Structure-Function Studies of Interleukin 15 using Site-specific Mutagenesis, Polyethylene Glycol Conjugation, and Homology Modeling* , 1997, The Journal of Biological Chemistry.

[80]  L. Wyns,et al.  Thiol pegylation facilitates purification of chymopapain leading to diffraction studies at 1.4 Å resolution , 1996 .

[81]  T. Tressel,et al.  Preparative electrofocusing for industrial applications. , 1996, Preparative biochemistry & biotechnology.

[82]  A A Poot,et al.  Proteins involved in the Vroman effect during exposure of human blood plasma to glass and polyethylene. , 1996, Biomaterials.

[83]  C. Bona,et al.  Purification of antigenized immunoglobulins derivatized with monomethoxypolyethylene glycol. , 1995, Journal of chromatography. A.

[84]  S. Shak,et al.  Modification of CD4 immunoadhesin with monomethoxypoly(ethylene glycol) aldehyde via reductive alkylation. , 1994, Bioconjugate chemistry.

[85]  K. Lund,et al.  Analytical gel filtration of dextran for the study of the glomerular barrier function. , 1993, Journal of chromatography.

[86]  G. Fortier,et al.  Surface modification of horseradish peroxidase with poly(ethylene glycol)s of various molecular masses : preparation of reagents and characterization of horseradish peroxidase-poly(ethylene glycol) adducts , 1993 .

[87]  M. Kurfürst Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1992, Analytical biochemistry.

[88]  G. Carrea,et al.  Circular dichroism and fluorescence of polyethylene glycol‐subtilisin in organic solvents , 1988, FEBS letters.

[89]  R. Maskiewicz,et al.  Analysis of polyethylene glycol modified superoxide dismutase by chromatographic, electrophoretic, light scattering, chemical and enzymatic methods. , 1988, Chemical & pharmaceutical bulletin.

[90]  S. G. Shafer,et al.  Cell separation by immunoaffinity partitioning with polyethylene glycol-modified protein A in aqueous polymer two-phase systems. , 1988, Journal of chromatography.

[91]  M. Potschka Universal calibration of gel permeation chromatography and determination of molecular shape in solution. , 1987, Analytical biochemistry.

[92]  S. G. Shafer,et al.  Immuno-affinity partition of cells in aqueous polymer two-phase systems. , 1986, Journal of chromatography.

[93]  Shigenoki Kuga Pore size distribution analysis of gel substances by size exclusion chromatography , 1981 .

[94]  F. Davis,et al.  Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.

[95]  P. Rempp,et al.  Étude par chromatographie en phase liquide de polystyrènes linéaires et ramifiés de structures connues , 1966 .